ACADIA Pharmaceuticals Overview
- Founded
- 1993

- Status
- Public
- Employees
- 580

- Stock Symbol
- ACAD

- Investments
- 1
- Share Price
- $53.66
- (As of Friday Closing)
ACADIA Pharmaceuticals General Information
Description
Acadia Pharmaceuticals is a biotechnology company that develops and commercializes biopharmaceutical products to address central nervous system disorders. The company aims to discover small molecule drugs that address disorders such as Parkinson's, Alzheimer's, and schizophrenia. Acadia also seeks to in-license or acquire complementary products and candidates. The company's patent applications claim proprietary technology, including novel methods of screening and chemical synthetic methods, novel drug targets, and novel compounds identified using its technology.
Contact Information
- 3611 Valley Centre Drive
- Suite 300
- San Diego, CA 92130
- United States
ACADIA Pharmaceuticals Stock Performance
(As of Friday Closing)
Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
---|---|---|---|---|---|---|
$53.66 | $54.46 | $30.02 - $58.72 | $8.53B | 159M | 1M | -$1.71 |
ACADIA Pharmaceuticals Financials Summary
In Thousands, USD |
TTM 30-Sep-2020 | FY 2019 31-Dec-2019 | FY 2018 31-Dec-2018 | FY 2017 31-Dec-2017 |
---|---|---|---|---|
EV | 5,902,541 | 5,915,630 | 2,109,129 | 3,373,207 |
Revenue | 419,074 | 339,076 | 223,807 | 124,901 |
EBITDA | (273,865) | (242,782) | (246,279) | (289,697) |
Net Income | (267,860) | (235,259) | (245,192) | (289,403) |
Total Assets | 795,664 | 783,183 | 540,202 | 384,506 |
Total Debt | 49,200 | 9,795 | 0 | 0 |
ACADIA Pharmaceuticals Valuation & Funding
Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
---|
This information is available in the PitchBook Platform. To explore ACADIA Pharmaceuticals‘s full profile, request access.
Request a free trialACADIA Pharmaceuticals Comparisons
Industry
0000 000
00000000
PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.
Request a free trialACADIA Pharmaceuticals Competitors (46)
Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
---|---|---|---|---|---|---|
SAGE Therapeutics | Formerly VC-backed | Cambridge, MA | 000 | 00.000 | 000000000 | 00.000 |
00000000 000000000 | Formerly VC-backed | Coral Gables, FL | 00 | 000.00 | 00000000 | 000.00 |
00 0000000 | Formerly Accelerator/Incubator backed | Paris, France | 00 | 000.00 | 000000000 | 000.00 |
000000000 00000000 | Corporation | Pasadena, CA | 000 | 00.000 | 000000 - 000 | 00.000 |
0000000000000 0000 | Formerly VC-backed | Cambridge, MA | 000 | 00000 | 00000000 | 00000 |
ACADIA Pharmaceuticals Executive Team (19)
ACADIA Pharmaceuticals Board Members (13)
Name | Representing | Role | Since |
---|---|---|---|
Daniel Soland | Self | Board Member | 000 0000 |
Edmund Harrigan MD | Self | Board Member | 000 0000 |
Julian Baker | Self | Board Member | 000 0000 |
Laura Brege | ACADIA Pharmaceuticals | Board Member | 000 0000 |
Stephen Biggar Ph.D | Self | Chairman & Board Member | 000 0000 |
ACADIA Pharmaceuticals Signals
Growth Rate

Growth

Size Multiple


Key Data Points
Twitter Followers
5.5k

Similarweb Unique Visitors
15.0K

Majestic Referring Domains
314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.
Request a free trialACADIA Pharmaceuticals Acquisitions (1)
Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
---|---|---|---|---|---|
000000 | 24-Aug-2020 | 000000000000000000 | 000.00 | Biotechnology | 0000000 00000 00 |
ACADIA Pharmaceuticals Subsidiaries (1)
Company Name | Industry | Location | Founded |
---|---|---|---|
000000 | Biotechnology | Dallas, TX | 0000 |